FDA Inspection
Fayz A. Hudefi, M.D.FDA Inspection 1204113 - Fayz A. Hudefi, M.D. - April 21, 2023
Record Details
This FDA Inspection record concerns Fayz A. Hudefi, M.D., with an inspection on April 21, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 0f9eb30e-0a46-4173-afa9-296053a02d79
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1204113
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.64(b)Safety Reports - Non-Serious Events
- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.64(b)Safety Reports - Non-Serious Events
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Fayz A. Hudefi, M.D.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| September 20, 2024 | VAI | Dallas District Office | Bioresearch Monitoring: Human Drugs |
| September 16, 2020 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Fayz A. Hudefi, M.D.
- FDA Inspection 1249620 - 2024-09-20
- FDA Inspection 1131413 - 2020-09-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.